A mitochondrial disease where broken energy production affects every high-demand organ — the heart, brain, muscles, and pancreas — requiring nutrition that supports mitochondrial function rather than restricting calories
MELAS stands for Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes. It is one of the most common mitochondrial diseases, caused most frequently (in approximately 80% of cases) by the m.3243A>G point mutation in mitochondrial DNA (mtDNA), which encodes a transfer RNA for leucine (MT-TL1). This mutation impairs mitochondrial protein synthesis, reducing the efficiency of the electron transport chain — the cellular machinery that converts nutrients into ATP (energy).
Because cells that are metabolically most active (neurones, cardiac muscle, skeletal muscle, pancreatic beta cells) depend most heavily on efficient mitochondrial ATP production, MELAS causes its most devastating effects in these tissues. The hallmark clinical features are stroke-like episodes (not caused by vessel occlusion but by energy failure in brain tissue), seizures, lactic acidosis (accumulation of lactate when cells shift to anaerobic metabolism), myopathy (muscle weakness), sensorineural hearing loss, diabetes mellitus, short stature, and cardiomyopathy.
The weight and nutritional picture in MELAS is complex — and very different from typical weight management. This article explains why standard weight loss approaches can be dangerous in MELAS, and what a metabolically appropriate nutritional strategy actually looks like.
MELAS cells cannot efficiently convert nutrients into ATP. When calorie intake is reduced significantly, or when fasting is prolonged, cells that are already energy-starved are pushed further into crisis. The body responds by ramping up anaerobic glycolysis — generating ATP inefficiently from glucose — producing large amounts of lactate as a byproduct. This drives lactic acidosis, which can cause vomiting, confusion, and in severe cases, life-threatening acidosis requiring emergency treatment.
For this reason, the nutritional goal in MELAS is NOT to create a calorie deficit — it is to optimise energy substrate delivery and support mitochondrial function. Weight loss, if pursued at all, must be extremely gradual (no more than 0.25 kg/week) and only under dietitian supervision.
MELAS-associated diabetes (Maternally Inherited Diabetes and Deafness, MIDD) is caused by progressive loss of pancreatic beta-cell function due to mitochondrial failure in islet cells. It presents like Type 1.5/LADA diabetes — initially insulin-secretion deficient but not autoimmune. Importantly:
Several common weight-loss interventions are dangerous in MELAS because they increase lactate production:
Mitochondrial myopathy causes progressive muscle weakness and reduced exercise capacity. Muscle mass is often low despite what may appear to be normal or high body weight — a phenomenon called sarcopenic obesity (low muscle, high fat). This means standard BMI and even body weight may underestimate the degree of muscle loss. DXA body composition scans are the preferred assessment tool.
Muscle wasting reduces resting metabolic rate further, meaning patients need fewer calories than expected for their size — making it easier to accumulate fat even at seemingly modest calorie intake.
Hypertrophic cardiomyopathy is present in a significant proportion of MELAS patients and limits aerobic exercise capacity. Cardiology clearance is required before any exercise programme. Moderate-intensity aerobic exercise is generally safe and beneficial if cardiac function is stable — vigorous exercise is not.
The nutritional goals in MELAS are:
Several supplements are commonly used in MELAS to support mitochondrial function. Evidence is largely based on biochemical rationale and small trials rather than large RCTs, but risk-benefit is generally favourable:
| Supplement | Dose (typical) | Rationale |
|---|---|---|
| Coenzyme Q10 (CoQ10 / Ubiquinol) | 300-1200 mg/day | Electron carrier in the respiratory chain; reduced in mitochondrial disease; ubiquinol form better absorbed |
| L-Carnitine | 2-3 g/day | Facilitates fatty acid transport into mitochondria; often depleted in mitochondrial myopathy |
| B vitamins (B1/thiamine, B2/riboflavin, B3/niacin) | As directed by specialist | Cofactors for mitochondrial enzyme complexes; riboflavin (B2) 100-400 mg/day particularly supported |
| Alpha-lipoic acid | 600 mg/day | Antioxidant; CoQ10 recycler; may reduce oxidative stress from dysfunctional mitochondria |
| L-Arginine | 0.5 g/kg IV during stroke-like episodes; 0.15-0.5 g/kg oral for prevention | Nitric oxide precursor; improves cerebrovascular blood flow during and after stroke-like episodes — this is a specialist-administered treatment |
| Vitamin C and E | 500-1000 mg / 400 IU daily | Antioxidants to reduce oxidative stress from dysfunctional electron transport |
All supplementation must be discussed with your metabolic physician. Self-prescribing high-dose supplements without medical oversight is not appropriate in a complex mitochondrial disease.
Exercise in MELAS must be moderate, consistent, and carefully monitored. The benefits — preserved muscle mass, improved cardiovascular fitness, better insulin sensitivity for MELAS diabetes, and improved psychological wellbeing — are real. The risks — lactic acidosis, triggering stroke-like episodes, cardiac events — are also real.
| Exercise Type | Suitable? | Notes |
|---|---|---|
| Low-to-moderate aerobic (walking, cycling, swimming) | Yes, with monitoring | Target 50-60% max heart rate; stop if unusual fatigue, muscle pain, nausea, or confusion |
| Light resistance training | Yes, carefully | Preserves muscle mass; avoid training to failure or maximal effort; rest between sets |
| Yoga / stretching / tai chi | Excellent | Low metabolic demand; balance and flexibility benefits; stress reduction |
| High-intensity intervals (HIIT) | Contraindicated | Anaerobic threshold exercise raises lactate sharply — stroke-like episode risk |
| Competitive sports / endurance events | Contraindicated | Too metabolically demanding; unpredictable stress response |
Carry glucose and a phone during all exercise. Exercise with a companion whenever possible. Stop and rest immediately at any warning sign: unusual muscle fatigue, muscle pain/cramps, nausea, headache, or visual changes — these may signal impending lactic acidosis or stroke-like episode.
If a MELAS patient has developed genuine excess adiposity (for example, from post-stroke disability reducing mobility, or from MELAS diabetes treatment causing weight gain), very gradual weight reduction may be appropriate. Guidelines:
MELAS and mitochondrial disease are managed by metabolic physicians and neurologists at tertiary centres. The primary centres are Wits Donald Gordon Medical Centre and Charlotte Maxeke Johannesburg Academic Hospital (Johannesburg), Red Cross War Memorial Children's Hospital and Groote Schuur Hospital (Cape Town), and Steve Biko Academic Hospital (Pretoria). Mitochondrial genetics testing is available through the National Health Laboratory Service (NHLS) at several sites.
The United Mitochondrial Disease Foundation (UMDF) provides patient education resources accessible to South African patients and families online.
Looking for more metabolic condition guides? Browse our full South African weight management library covering mitochondrial disorders, rare metabolic conditions, and complex endocrine diseases.